Christine Van Broeckhoven does research on Alzheimer dementia,[1][2] bipolar mental disorders and other neurological diseases.

Since 1983 she has had her own laboratory for molecular genetics at the University of Antwerp, and since 2005 is focussing her research on neurodegenerative brain diseases.

[3] For her achievements as a scientist, Van Broeckhoven received the Belgian Quinquennial Prize of the Belgian National Science Foundation and in 1993 she and three other scientists were awarded the American Potamkin Prize for their work on the amyloid precursor protein (APP) which can cause severe, early Alzheimer's disease.

Van Broeckhoven headed the list for the Belgian Chamber of People's Representatives in the province of Antwerp.

She retired from politics after the 2010 Belgian general election to concentrate on her scientific work.